Phase II studies of combinations of drugs with high dose carboplatin in neuroblastoma (800 mg/m2 to 1 g 250/m2): a report from the LMCE group.
D016190:Carboplatin; D002330:Carmustine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000627:therapeutic use*; D006801:Humans; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D009447:Neuroblastoma / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000627:therapeutic use* / Q000633:toxicity
D009944:Organoplatinum Compounds; D008734:Methoxyhydroxyphenylglycol; D005047:Etoposide; D016190:Carboplatin; D002330:Carmustine